En español
NIDA

Dr. Elizabeth F. Howell

March 31, 2014

Audio

To listen to this podcast, click "Download the MP3" (requires Windows Media Player or Real Media Player) or "Listen Now" (requires Adobe Flash Player).

Listen Now:

Length: 02.27 minutes | Download the MP3 (2MB)

Video

Transcript

So as a member of the council, I’m supposed to go to the meetings three times a year, and in between our meetings, we will have some times that we review proposals—grant proposals that have already gone through a first level of review.

The bottom line is, we have to concur or not with what the first-level of review people have done, you know, do we really concur with the decisions of the review committee?

But, we also get to comment on things like, are there concerns about human subjects, are there concerns about animal research, etcetera, etcetera.

The meetings are always split, so the first half, or the first day, is a closed session.

But the following day is open to the public, and it is often—I think it’s webcast—and it is really pretty well attended by members of the advocacy community, the professional organizations, and they can take the information from that meeting to their groups.

By statute, there have to be 12 researchers, I don’t remember the exact language of how they’re described, and then there are 6 members that are from the general public.

As an educator and a clinician, what I learn about at the meetings really helps me bring back the latest trends in what people are considering to be helpful for addiction.

This page was last updated March 2014

NIDA Notes

Tags

Drug Topics

Drugs of Abuse

Population Groups

Related Topics

Get this Publication

    Contact Press Office

    301-443-6245
    (8:30-5:30 ET)
    media@nida.nih.gov